Related references
Note: Only part of the references are listed.Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
Luz Martin-Carbonero et al.
AIDS (2011)
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A. M. Evens et al.
ANNALS OF ONCOLOGY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S. J. Patterson et al.
GUT (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Virological Breakthrough and Resistance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogues in Clinical Practice
Chanunta Hongthanakorn et al.
HEPATOLOGY (2011)
A Proposed, Evidence-based Approach to the Treatment of Chronic Hepatitis B
Steven-Huy B. Han et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Evaluation of current treatment recommendations for chronic hepatitis B: A 2011 update
Myron John Tong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Chronic hepatitis B in Asia-new insights from the past decade
Henry Lik-Yuen Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Natural history of chronic hepatitis B REVEALed
Chien-Jen Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatitis D revival
Heiner Wedemeyer
LIVER INTERNATIONAL (2011)
Chronic Hepatitis B and Hepatocellular Carcinoma
Amy C. McClune et al.
CLINICS IN LIVER DISEASE (2010)
Surveillance for Hepatocellular Carcinoma Improves Survival in Asian-American Patients with Hepatitis B: Results from a Community-Based Clinic
Myron J. Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
Jurrien G. P. Reijnders et al.
GASTROENTEROLOGY (2010)
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
Thomas Berg et al.
GASTROENTEROLOGY (2010)
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
Myron John Tong et al.
HEPATOLOGY INTERNATIONAL (2010)
Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period
Neung Hwa Park et al.
INTERVIROLOGY (2010)
Survival in Asian Americans After Treatments for Hepatocellular Carcinoma A Seven-year Experience at UCLA
Myron J. Tong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
John S. Lubel et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2010)
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
R. G. Gish et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion
Yuan-Hung Kuo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Hepatitis D: Scenario in the Asia-Pacific region
Zaigham Abbas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir
Won Hyeok Choe et al.
ANTIVIRAL THERAPY (2009)
Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
Myron John Tong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV-Infected Individuals: A Cohort Study and Meta-Analysis
Georgios K. Nikolopoulos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis
Myron John Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Hepatitis B and Human Immunodeficiency Virus Coinfection
Chloe L. Thio
HEPATOLOGY (2009)
The Natural History of Chronic Hepatitis B Virus Infection
Brian J. McMahon
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
W. -M. Xu et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Analysis of the efficacy of treatment with peginterferon α-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus
Jian-Wu Yu et al.
LIVER INTERNATIONAL (2009)
Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
Yun-Fan Liaw
LIVER INTERNATIONAL (2009)
Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination
Xiaofeng Liang et al.
VACCINE (2009)
Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy
Rohit Loomba et al.
ANNALS OF INTERNAL MEDICINE (2008)
Treatment recommendations for chronic hepatitis B: An evaluation of current guidelines based on a natural history study in the United States
Myron John Tong et al.
HEPATOLOGY (2008)
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
Teerha Piratvisuth et al.
HEPATOLOGY INTERNATIONAL (2008)
Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues
Nancy Leung
HEPATOLOGY INTERNATIONAL (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment
Chi-Jen Chu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy
Jeng-Hsiu Hung et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2008)
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
Jinlin Hou et al.
HEPATOLOGY (2008)
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
M-F Yuen et al.
GUT (2008)
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B
Chih-Lin Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis
Grace Lai-Hung Wong et al.
LIVER INTERNATIONAL (2008)
Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers
Myron J. Tong et al.
LIVER INTERNATIONAL (2007)
Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
S. G. Lim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China
Guangbi Yao
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
Chee-Kin Hui et al.
HEPATOLOGY (2007)
Revisiting the natural history of chronic hepatitis B: Impact of new concepts on clinical management
Man-Fung Yuen
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Brief report - The HBV drug entecavir - Effects on HIV-1 replication and resistance
Moira A. McMahon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Care of patients coinfected with HIV and hepatitis C virus:: 2007 updated recommendations from the HCV-HIV International Panel
Vincent Soriano et al.
AIDS (2007)
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
Chih-Lin Lin et al.
HEPATOLOGY (2007)
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab
Michiko Yamagata et al.
LEUKEMIA & LYMPHOMA (2007)
Long-term outcome of chronic hepatitis B based on histological grade and stage
Byung Kyu Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Management of hepatitis B: Summary of a clinical research workshop
Jay H. Hoofnagle et al.
HEPATOLOGY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma
Myron J. Tong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: A case-control study
Chun-Jen Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers
CJ Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Hepatitis B virus-related cirrhosis: Natural history and treatment
CM Chu et al.
SEMINARS IN LIVER DISEASE (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
MF Yuen et al.
GUT (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection
M Onozawa et al.
TRANSPLANTATION (2005)
How to predict HCC development in patients with chronic B viral liver disease?
KH Han et al.
INTERVIROLOGY (2005)
Hepatitis B Virus: Inactive carriers
Sanjeev Kumar Sharma et al.
VIROLOGY JOURNAL (2005)
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
HLY Chan et al.
GUT (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study
MF Yuen et al.
CARCINOGENESIS (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
MG Peters et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: Univariate and multivariate analysis
MF Chen et al.
WORLD JOURNAL OF SURGERY (2003)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
JH Kao et al.
GASTROENTEROLOGY (2003)
Natural history and prognosis of hepatitis B
G Fattovich
SEMINARS IN LIVER DISEASE (2003)
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations
MF Yuen et al.
JOURNAL OF HEPATOLOGY (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Core promoter mutations (A1762T and G1764A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China
ZL Fang et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Primary infection with a lamivudine-resistant hepatitis B virus
V Thibault et al.
AIDS (2002)
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications
MF Yuen et al.
HEPATOLOGY (2001)
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
RP Perrillo et al.
HEPATOLOGY (2001)
Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy
C Manegold et al.
CLINICAL INFECTIOUS DISEASES (2001)
Chronic hepatitis B virus infection in Asian countries
I Merican et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B
SNS Ahmed et al.
HEPATOLOGY (2000)
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma
CM Chu
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient
D Mutimer et al.
GUT (2000)
Share Paper
